Activation of HOX11L2 by juxtaposition with 3′-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2)

Genes Chromosomes and Cancer

Volumn 37, Issue 1, 2003, Pages 84-91

  MacLeod, Roderick A F ^a   Nagel, Stefan ^a   Kaufmann, Maren ^a   Janssen, Johannes W G ^b   Drexler, Hans G ^a  

^a Department of Cell Cultures ^*  (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; CHROMOSOME 14Q; CHROMOSOME 5Q; CHROMOSOME BREAKAGE; CYTOGENETICS; GENE ACTIVATION; HUMAN; LEUKEMIA CELL LINE; PRIORITY JOURNAL; REGULATORY MECHANISM; T CELL LEUKEMIA;

CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 5; CYTOGENETIC ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, T-CELL, ACUTE; NEOPLASM PROTEINS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0037403157     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10194     Document Type: Article

References (18)

1. Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M, van den Akker J, Perot C, Pellegrino B, Landman-Parker J, Douay L, Berger R, Bernard OA. 2003. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood. 2002;100:991-997.
2. Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffe M, Della Valle V, Monni R, Nguyen, Khac F, Mercher T, Penard-Lacronique V, Pasturaud P, Gressin L, Heilig R, Daniel MT, Lessard M, Berger R. 2001. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 15:1495-1504.
3. Brake RL, Kees UR, Watt PM. 1998. Multiple negative elements contribute to repression of the HOX11 proto-oncogene. Oncogene 17:1787-1795.
4. Drexler HG. 2001. The leukemia-lymphoma cell line facts book. San Diego: Academic Press.
5. Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff C. 2001. Catalogue of human and animal cell lines, 8th ed. Braunschweig, Germany: DSMZ.
6. Drexler HG, Dirks WG, Matsuo Y, MacLeod RAF. 2003. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17:416-426.
7. Ferrando AA, Neuberg DS, Staunton J, Log ML, Huard C, Raimondi SC, Behm FG, Pui C-H, Downing GR, Gililland DG, Lander ES, Golub TR, Look AT. 2002. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1:75-87.
8. Hansen-Hagge TE, Schäfer M, Kiyoi H, Morris SW, Whitlock JA, Koch P, Bohlmann I, Mahotka C, Bartram CR, Janssen JWG. 2002. Disruption of the RanBP17/Hox11L2 region by recombination with the TCRδ locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). Leukemia 16:2205-2212.
9. Helias C, Leymarie V, Entz-Werle N, Falkenrodt A, Eyer D, Costa JA, Cherif D, Lutz P, Lessard M. 2002. Translocation t(5;14)(q35;q32) in three cases of childhood T cell acute lymphoid leukemia: a new recurring and cryptic abnormality. Leukemia 16:7-12.
10. Koch P, Bohlmann I, Schafer M, Hansen-Hagge TE, Kiyoi H, Wilda M, Hameister H, Bartram CR, Janssen JWG. 2000. Identification of a novel putative Ran-binding protein and its close homologue. Biochem Biophys Res Commun 278:241-249.
11. Langston AW, Thompson JR, Gudas LJ. 1997. Retinoic acid-responsive enhancers located 3′ of the Hox A and Hox B homeobox gene clusters. Functional analysis. J Biol Chem 272:2167-2175.
12. Lindeskog M, Blomberg J. 1997. Spliced human endogenous retroviral HERV-H env transcripts in T-cell leukaemia cell lines and normal leukocytes: alternative splicing pattern of HERV-H transcripts. J Gen Virol 78:2575-2585.
13. MacLeod RAF, Drexler HG. 2003. Cytogenetic characterization of tumor cell lines. In: Langdon S, editor. Cancer cell culture - methods and protocols. Totowa, NJ: Humana Press.
14. MacLeod RAF, Nagel S, Greulich-Bode K, Kaufmann M, Drexler HG. 2002. Multicolor FISH analysis of a natural killer cell line (NK-92). Leukemia Res 26:1027-1033.
15. Morikawa S, Tatsumi E, Baba M, Harada T, Yasuhira K. 1978. Two E-rosette-forming lymphoid cell lines. Int J Cancer 21:166-170.
16. Nezu J, Oku A, Jones MH, Shimane M. 1997. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics 45:327-331.
17. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, Siebert R, Tucker PW, Dyer MJ. 2001. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98:3413-3420.
18. Ting CN, Rosenberg MP, Snow CM, Samuelson LC, Meisler MH. 1992. Endogenous retroviral sequences are required for tissue-specific expression of a human salivary amylase gene. Genes Dev 6:1457-1465.